WRK 1 cells were labelled to equilibrium with 2-myo-[3H]inositol and stimulated with vasopressin. Within 3 s of hormone stimulation there was a marked accumulation of 3H-labelled InsP2 and InsP3 (inositol bisand tris-phosphate), but not of InsP (inositol monophosphate). There was an associated, and rapid, depletion of 3H-labelled PtdlnsP and PtdInsP2 (phosphatidylinositol mono-and bis-phosphates), but not of Ptdlns (phosphatidylinositol), in these cells. Some 4% of the radioactivity in the total inositol lipid pool of WRK 1 cells was recovered in InsP2 and InsP3 after 10 s stimulation with the hormone. The selectivity of the vasopressin receptors of WRK 1 cells for a variety of vasopressin agonists and antagonists revealed these to be of the Via subtype. There was no receptor reserve for vasopressin-stimulated inositol phosphate accumulation in WRK 1 cells. The accumulation of inositol phosphates was enhanced in the presence of Li+ ions. Half-maximal accumulation of InsP, InsP2 and InsP3 in vasopressin-stimulated cells was observed with 0.9, 3.0 and 3.6 mM-Li+ respectively. Bradykinin and 5-hydroxytryptamine also provoked inositol phosphate accumulation in WRK 1 cells. The effects of sub-optimal concentrations of bradykinin and vasopressin upon inositol phosphate accumulation were additive, but those of optimal concentrations of the hormones were not.
INTRODUCTION
Many hormones and neurotransmitters that influence intracellular events via Ca2+-mediated protein phosphorylation share a common mechanism of signal transduction which involves receptor-mediated PtdIns (4,5)P2 degradation and the mobilization of InsP3 and diacylglycerol as second messengers (see refs. [1, 2] for reviews). Such ligands include vasopressin, which interacts with specific V,-receptors in liver [3] [4] [5] , vascular smooth msucle [6] and the sympathetic nervous system [7] to provoke inositol-lipid breakdown and intracellular Ca2+ mobilization.
Monaco and her co-workers [8, 9] have previously shown that vasopressin enhances protein accumulation and the incorporation of [14C]acetate into lipids in WRK 1 cells, a cloned cell line derived from a chemically induced mammary tumour. These effects were associated with a marked stimulation of [32P]P1 incorporation into Ptdlns [10] [11] [12] . In the preceding paper [13] we demonstrated that vasopressin binds to a single class of Vl-receptors on WRK 1 cells. It is now clear that V1-receptor-mediated Ptdlns labelling in liver [4, 5, [14] [15] [16] [17] [18] [19] [20] and other tissues (see refs. [1, 2] for reviews) is associated with the prior degradation of PtdIns(4,5)P2 and the associated accumulation of the Ca2+-mobilizing second messenger InsP3.
In the present study we have characterized the accumulation of inositol phosphates provoked by vasopressin and other ligands in WRK 1 cells. We provide evidence that several hormones share a common mechanism of signal transduction, involving Ptdlns(4,5)P2 degradation, in these cells.
MATERIALS AND METHODS Cell culture and incubation
WRK cells were established and grown as described in the previous paper [13] , except that myo-[2-3H]inositol (2 ,Ci/ml) was included in the culture medium for the entire period during which the cells were grown on 35 mm-diameter plastic Petri dishes before experimentation. After 4 days in the presence of myo- [2-3H] inositol, when the cell density was about (5) (6) (7) x 105 cells/dish, the culture medium was aspirated and replaced with 1.5 ml of non-radioactive and serum-free medium. The cells were incubated for a further 1 h at 37°C before the medium was aspirated again and the cells washed with 2 ml of PBS. The cells were then bathed in 2 ml of fresh PBS and maintained at 37°C for the rest of the experiment. Where appropriate, LiCl was added to incubations 10 min before the addition of hormones or other ligands. When Li+ was present, the concentration of Na+ in PBS was reduced appropriately so as to maintain a constant ionic strength. Incubations were terminated by aspirating the PBS and replacing it with 1 ml of HC104 (5%, v/v). Extraction and separation techniques After the termination of experimental incubations, cells were scraped from the plastic substratum of the dish with a rubber policeman in the presence of 2 mg of bovine serum albumin (fraction 5). The entire acid extract was transferredto a small glass tube and the Petri dishes were rinsed witl 1 ml of HCl04 (1%, v/v). The combined acid extract was centrifuged at 2000 g for 5 min and the protein pellet retained for lipid extraction. The supernatant was neutralized with 1.5 M-KOH containing 75 mM-Hepes in the presence of universal indicator. KC 104 was precipitated at 0°C for 2 h and removed by brief centrifugation. The neutralized acid extracts were diluted to 12 ml with 5 mM-Na2B407/ 0.5 mM-EDTA, and inositol phosphates were separated by ion-exchange chromatography on Dowex 1 (Xl0, 100-200 mesh; formate form) as described previously [7, 20] . We have found that the extraction procedure described above routinely yields results identical with those obtained with the trichloroacetic acid extraction described by others [21] . However, our method is very much simpler and does not necessitate repeated extractions with diethyl ether to remove the trichloroacetic acid.
The HC104-precipitated protein pellet was washed with 1 ml of water and the lipids extracted as described previously [4] . Lipid extracts were dried, re-suspended in 0.5 ml of chloroform and deacylated by alkaline hydrolysis [4] . The water-soluble (and 3H-labelled) products of this deacylation were separated by anionexchange chromatography as described previously [4] .
Chemicals
Synthetic vasopressin analogues used in the present study were generously given by Professor M. Manning, Medical College of Ohio, Toledo, OH, U.S.A., and are listed in the preceding paper [13] . Other peptides and receptor agonists were from Penninsula Laboratories, Sigma or Bachem. myo-[2-3H]Inositol was from New England Nuclear. Other chemicals were of the highest grade available and from the sources given previously [4, 5, 7, 13] . [1, 2] for reviews), is the breakdown of PtdIns4P and/or PtdIns(4,5)P2. The present results do not indicate whether the hormone stimulates the breakdown of both these lipids or merely the latter, with InsP2 accumulating as a result of monoesterase attack upon InsP3 and PtdIns4P becoming depleted due to the resynthesis of Ptdlns(4,5)P2. In either case, it seems most likely that Ptdlns is ultimately depleted as a consequence of its utilization in polyphosphoinositide resynthesis and that InsP accumulates as a result of phosphomonoesterase attack upon InsP2 and InsP3. The initial rate for the accumulation of [3H]InsP2 and [3H]InsP3 in vasopressin-stimulated cells was considerable: 4% of the radioactivity associated with all inositol lipids appeared in these products after 10 s stimulation with the hormone, although the radioactivity of the inositol lipids themselves fell by only 1 % over the same time period. This represents an initial rate of inositol phosphate accumulation that is very much greater than that which we have previously observed in vasopressinstimulated hepatocytes [5] . The discrepancy between the accumulation of radioactivity in inositol phosphates of stimulated cells and the loss of radioactivity from the parent lipids presumably reflects lipid resynthesis from the [3H]inositol pool retained within the cell. Such compensatory resynthesis of inositol lipids after their receptor-mediated hydrolysis has previously been obser- [3H]Inositol-labelled WRK cells were washed free of culture medium and bathed in PBS containing 1O mM-LiCl. [8-lysine] Vasopressin (0.2 ,uM, 0) or control (0) additions were made 10 min later and incubations were terminated at the times indicated. Individual inositol phosphates and the deacylation products ofthe inositol lipids were extracted and separated by anion-exchange chromatography as described in the Materials and methods section. Results are means+S.E.M. of three determinations from a single experiment, typical of three. Where no error bars are shown, these are contained within the symbols.
ved in other systems [4, 14, 15] . The availability of [3H]Ins is unlikely to have been rate-limiting to inositol-lipid resynthesis in the present study, since the radioactivity in the free inositol pool of unstimulated cells was four times that released in total inositol phosphates after 6 min stimulation with vasopressin (results not shown).
The results in Figs. 1 and 2 clearly indicate that vasopressin provokes an initial and rapid accumulation of InsP2 and InsP3 during the first 10-30 s of stimulation, which is followed by a slower, but sustained, accumulation of all three inositol phosphates. The diminished rate of accumulation of InsP2 and InsP3 after longer periods of stimulation is not merely a consequence of the hydrolysis of these compounds to InsP, since insufficient radioactivity appears in this fraction to account for the decreased accumulation of [3H]InsP2 and [3H]InsP3. It is possible that these kinetics reflect an initial hydrolysis of a hormone-sensitive pool of Ptdlns(4,5)P2, whose further breakdown is limited by the Vol. 240 rate at which it can be replenished from the Ptdlns and PtdIns4P reserves of the cell.
While this paper was in an advanced stage of preparation, Koreh & Monaco [46] reported that vasopressin provokes the depletion of Ptdlns(4,5)P2 and the associated accumulation of inositol phosphates in WRK 1 cells. The results of these workers also revealed that 60% of the cellular Ptdlns(4,5)P2 pool, and the entire complement of this lipid sensitive to hormone-stimulated hydrolysis, is synthesized from the relatively small proportion (17%) of the cellular pool of Ptdlns, that is also sensitive to vasopressin-stimulated depletion. This result confirms previous evidence, and that reported herein, that points to the existence of a discrete, hormone-sensitive, pool of inositol phospholipids in WRK 1 cells [ 1 1,12] .
The concentration-dependence of the vasopressinstimulated accumulation of inositol phosphates in WRK 1 cells is shown in Fig. 3 . The concentration of vasopressin required to provoke half-maximal accumulation of all three inositol phosphates was of the order of 3 nm. This is very similar to both the affinity of the WRK 1 cell Via-receptor for vasopressin [13] , and also to the concentration of the hormone required to cause half-maximal inositol lipid depletion and/or inositol phosphate accumulation in a number of other tissues [4, 7, [14] [15] [16] [17] .
The relationship between the concentrations of a variety of vasopressin analogues required to provoke half-maximal accumulation of inositol phosphates in WRK 1 cells and those required to half-saturate WRK 1 cell Vla-receptors is shown in Fig. 4 . Also shown in this Figure is the relationship between the concentrations of various vasopressin antagonists that were required to half-maximally inhibit inositol phosphate accumulation and receptor occupation by a sub-optimal concentration of [8-lysine] vasopressin. The influence of antagonists upon vasopressin-induced inositol-phosphate accumulation was investigated in experiments similar to those shown in Fig. 5 . The relative potencies of the ligands in Fig. 4 provides further evidence that the vasopressin receptors on WRK 1 cells are of the Via subtype [13, 22] .
There was a close correlation between receptor occupa-tion by these peptides and their ability to influence inositol phosphate accumulation. This indicates that there is no 'receptor reserve' for Vla receptor-mediated inositol phosphate accumulation in these cells. We have previously argued that the absence of a receptor reserve for agonist-induced inositol lipid depletion in several tissues is compatible with the notion that receptormediated inositol lipid breakdown is involved in the I-10 where IC50 is the antagonist concentration provoking a 50% inhibition of the vasopressin-induced response, [VP] is the concentration of [8-lysine] vasopressin present in the assay (10 nM) and Ka is the concentration of [8- lysine]vasopressin which evokes a half-maximal stimulation of inositol phosphate accumulation. Results are means of duplicate determinations in a single experiment typical of three to six which were averaged to give the data shown in Fig. 4 . mechanism of signal transduction at the plasma membrane [4, 14, 15, 23] . The present results provide further support for this idea.
Influence of [Li+] upon vasopressin-stimulated inositol phosphate accumulation in WRK 1 cells
As has been found in other tissues, Li+ enhances the accumulation of inositol phosphates in vasopressinstimulated WRK 1 cells (Fig. 6 ). This effect has generally been attributed to the ability of Li+ to inhibit InsiP phosphatase [24, 25] . However, in WRK 1 cells, the accumulation of all three inositol phosphates was enhanced in the presence of Li+. Half-maximal accumulation of InsP in vasopressin-stimulated cells was observed with 0.9 mM-Li+. Maximal accumulation ofInsP occurred with 3 mM-Li+, and the accumulation of this product [3H]Inositol-labelled WRK cells were washed free of culture medium and bathed in PBS containing various concentrations of LiCl. [8-lysine] Vasopressin (2 x 10-7 M, 0) or control additions (0) were made 10 min later and incubations were terminated after a further 6 min. The radioactivity recovered in individual inositol phosphates was determined after anion-exchange chromatography as described in the Materials and methods section. The radioactivity recovered in the total inositol lipids of unstimulated cells was 1800+92 d.p.m./104 cells (n = 6). Results are means + S.E.M. of three determinations from a single experiment, typical of three. Where no error bars are shown, these are contained within the symbols. Table 1 . Agonists that failed to influence inositol phosphate accumulation in WRK 1 cells WRK 1 cells were cultured with myo-[2-3H]inositol and incubated in the presence of 10 mM-Li+ as described in the text. Agonists were added to give the final concentrations indicated. Incubations were terminated 6 min later and inositol phosphates separated and assayed for radioactivity as described in the text. All agonists were tested for inositol-phosphate-releasing activity in at least two separate experiments. [26] [27] [28] [29] [30] [31] . In liver, at least, these include both membrane-bound and soluble activities [26, 29] . The observation that vasopressin-stimulated InsP2 accumulation is greatly increased by Li+ in WRK 1 cells suggests that the dephosphorylation of this product may occur mainly via the Ins(1,4)P2 4-phosphatase route, which we have found to be cytosolic and sensitive to The ability of Li+ to enhance InsP3 acumulation in WRK 1 cells and hepatocytes contrasts with the failure of this ion to influence InsP3 5-phosphatase activity in hepatocytes [26] or platelets [31] . However, it is now clear that two isomers of InsP3 accumulate in stimulated cells. The product of PtdIns(4,5)P2 hydrolysis would be expected to be Ins (1, 4, 5) P3, but Ins (1, 3, 4) P3 is the predominant isomer found in parotid gland [32] , hepatocytes [5] , HL60 cells and pancreatic acinar cells [33] that have been stimulated for more than a few seconds. Our own preliminary results indicate that Ins (1, 3, 4) P3 is the major InsP3 isomer to accumulate in WRK 1 cells that have been stimulated with vasopressin for 6 minutes (C. J. Barker, S. McCallum & C. J. Kirk, unpublished work) . Ins(l,3,4)P3 is probably derived from a novel InsP4, Ins (1, 3, 4, 5) P4, which has recently been shown to accumulate in ligand-stimulated brain slices [34] , hepatocytes [5] Influence of other agonists on inositol phosphate accumulation in WRK 1 cells Apart from vasopressin, a large number of other agonists were screened for their ability to provoke inositol phosphate accumulation in WRK 1 cells. Many of these were without effect ( Table 1) , but bradykinin, and 5-hydroxytryptamine did cause significant accumulation of inositol phosphates in these cells ( Table 2 ). Both these agonists have previously been shown to stimulate Ptdlns(4,5)P2 depletion and/or inositol phosphate accumulation in other tissues [35, 36] and it seems likely that these hormones provoke receptor-mediated hydrolysis of PtdIns(4,5)P2 in WRK 1 cells too.
The concentration-dependence of bradykinin-stimulated inositol phosphate accumulation in WRK 1 cells is shown in Fig. 7 . Half-maximal accumulation of InsP2 and InsP3 was observed in the presence of about 5 nM-bradykinin. This is very similar to the concentration of bradykinin required to half-saturate the bradykinin receptors of intestinal smooth muscle and mucosal cells [37, 38] , which suggests that, as we have previously argued for vasopressin receptors [4, 14, 15] , Ptdlns(4,5)P2 breakdown may be closely coupled to bradykininreceptor occupation.
Also shown in Fig. 7 is the influence of sub-maximal and maximal concentrations of vasopressin upon the accumulation of InsP2 and InsP3 provoked by a range of concentrations of bradykinin in WRK 1 cells. In the presence of concentrations of vasopressin that were themselves sufficient to provoke only a modest accumulation of inositol phosphates, the effects of the two hormones appeared to be virtually additive. However, when the cells were exposed to a concentration of [3H]Inositol-labelled WRK 1 cells were washed free of culture medium and bathed in PBS containing 10 mM-LiCl. After 10 min, the cells were exposed to various concentrations of either bradykinin alone (@) or bradykinin plus 1.5 nM-(OJ), 7.5 nM-(A) or 190 nM-(*)[8-lysinelvasopressin. Incubations were terminated after 6 min stimulation and the radioactivity recovered in InsP2 and InsP3 was determined after anion-exchange chromatography as described in the text. Results are means+S.E.M. of three determinations from a single experiment, typical of two. Where no error bars are shown, these are contained within the symbols.
vasopressin sufficient to cause maximal vasopressininduced inositol phosphate production, bradykinin (0.2 ftM) caused little further accumulation of these products. These results suggest that the two hormones share at least some common elements in the mechanism(s) by which they hydrolyse inositol lipids in WRK 1 cells, and that one such element becomes saturated in the presence of maximal concentrations of both hormones. The saturable element could be the GTP-dependent coupling protein, which appears to couple the activated receptor to a membrane-bound inositol-lipid phosphodiesterase in WRK 1 [39] and other cells [40] [41] [42] [43] , this enzyme or the availability of the inositol lipid itself.
The present results clearly demonstrate that WRK 1 cells carry vasopressin receptors of the Vla subtype and receptors for other hormones which are coupled to the hydrolysis of membrane inositol phospholipids. It seems likely that the primary consequence ofreceptor activation is the hydrolysis of Ptdlns(4,5)P2 to yield InsP3 and diacylglycerol. Both these products have been suggested to fulfil 'second-messenger' roles within the cell. InsP3 causes Ca2+ mobilization from an intracellular store (see ref. [2] for review) and diacylglycerol is a physiological activator of protein kinase C (see ref. [44] for review). These two intracellular messengers act synergistically to provoke the phosphorylation of a variety of enzymes in target cells [2, 44, 45] . The physiological consequences of the release of these messengers inside WRK 1 cells is not yet clear, but they may be involved in the stimulation of protein and lipid synthesis observed in the presence of vasopressin [8, 9] .
